Leprosy control in the Northern Territory

Australian and New Zealand Journal of Public Health

Volumn 22, Issue 6, 1998, Pages 709-713

  Merianos, Angela ^a  

^a MINISTRY OF HEALTH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; FEMALE; HEALTH CARE PERSONNEL; HUMAN; LEPROSY; LEPROSY CONTROL; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PLASTIC SURGERY; PUBLIC HEALTH; RELAPSE;

EID: 0032426808     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842x.1998.tb01475.x     Document Type: Article

References (7)

1. Cook C. The epidemiology of leprosy in Australia. Service publication no. 38. Canberra: Commonwealth of Australia, Dept of Health, 1927.
2. Hargrave JC. Leprosy in the Northern Territory of Australia [thesis]. New South Wales: University of Sydney, 1975: 275.
3. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int J Lepr 1966; 34: 255-75.
4. National Health and Medical Research Council. Surveillance case definition. March 1994. National Health and Medical Research Council (Australia). Public Health Committee. Surveillence case definitions: endorsed at the 115th session of the NHMRC. Adelaide, June 1993, report of the Public Health Committee, NHMRC. Canberra: Australian Government Publishing Service, 1994.
5. Dash MS. A study of conduction velocity of sensory fibres of the ulnar nerve in leprosy. Int J Lepr 1967; 35: 460-9.
6. Cho SN, Yanagihara DL, Hunter SW, et al. Serological specificity of phenolic glycolipid from Mycobacterium leprae and its use in the serodiagnosis of leprosy. Infect Imm 1983; 41(3): 1077-83.
7. Chin-a-lien RAM, Faber WR, van Rens MM, et al. Follow up of multibacillary patients using a phenolic glycolipid-1-based ELISA. Do increasing ELISA-values after discontinuation of treatment indicate relapse. Lepr Rev 1982; 63: 21-27.